Please assess the completion status of the following clinical trial:

Trial Title: Allogeneic Hematopoietic Stem Cell Transplantation in HIV-1 Infected Patients

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* HIV-1 infection, requiring allogeneic, haematopoietic SCT as determined by their treating Physician (Haematologist).~* Over 18 years of age~* Provision of written, informed consent~Exclusion Criteria:~* In the opinion of the investigator that the patient is not able to provide informed consent~* Hb \< 9 (g/dL)~* CD4+ T cell count \<100 (cells/µl)~* Serious coagulation abnormalities, platelet count \< 50.~* Patients currently taking medications that significantly affect the bleeding time (e.g. warfarine, clexane, FXa antagonists)~* History of allergy to local anaesthetics~* Pregnancy

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).